Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H4ClNOS |
Molecular Weight | 149.599 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1SC(Cl)=CC1=O
InChI
InChIKey=DHNRXBZYEKSXIM-UHFFFAOYSA-N
InChI=1S/C4H4ClNOS/c1-6-4(7)2-3(5)8-6/h2H,1H3
Molecular Formula | C4H4ClNOS |
Molecular Weight | 149.599 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.cosmeticsinfo.org/ingredient/methylisothiazolinone-and-methylchloroisothiazolinoneCurator's Comment: description was created based on several sources, including:
DOI: 10.1007/978-3-642-55706-4_7
http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/mci_mi/mci_mi_pc_en.pdf
Methylisothiazolinone/Methylchloroisothiazolinone (Kathon CG) Allergy: An Updated Review.
Sources: http://www.cosmeticsinfo.org/ingredient/methylisothiazolinone-and-methylchloroisothiazolinone
Curator's Comment: description was created based on several sources, including:
DOI: 10.1007/978-3-642-55706-4_7
http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/mci_mi/mci_mi_pc_en.pdf
Methylisothiazolinone/Methylchloroisothiazolinone (Kathon CG) Allergy: An Updated Review.
Methylchloroisothiazolinone is an active ingredient in many preservatives marketed under various brand names. It is effective against gram-positive and gram-negative bacteria, yeast, and fungi. Pure Methylchloroisothiazolinone is not commercially available. Kathon CG contains a mixture of Methylisothiazolinone (MI) and Methylchloroisothiazolinone (MCI) in ratio 3:1. Kathon was used in various rinse-off and leave-on formulations including hair products, shampoos, skin care products, bath products, eye and facial makeup, wet wipes and suntan products. The Commission envisages amending Annex V of the Cosmetics Regulation (EC) No. 1223/2009 to restrict the use of methylchloroisothiazolinone to rinse-off products, as suggested by the SCCS.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0009060 Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
|||
Target ID: CHEMBL2096668 Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
|||
Target ID: ATP synthesis Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
|||
Target ID: GO:1903409 Sources: http://www.ppchem.com/free/ppchem-01-2007-2.pdf |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | TRUE Test Approved Use5-chloro-2-methyl-4-isothiazolin-3-one (1.05% to 1.25% w/w) and 2-methyl-4-isothiazolin-3-one (0.25% to 0.40%
w/w) in a 3:1 ratio at a concentration of 1.5% in aqueous magnesium salts are used to formulate patch #17 |
PubMed
Title | Date | PubMed |
---|---|---|
Audit of Finn Chamber patch test preparation. | 2002 Dec |
|
Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes. | 2003 Aug |
|
Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells. | 2003 Feb |
|
Contact sensitization to 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one in children. | 2003 Oct |
|
Covalent binding of the 13C-labeled skin sensitizers 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) to a model peptide and glutathione. | 2004 Jan 19 |
|
Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin: identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry. | 2004 Sep |
|
From experiment to theory: molecular orbital parameters to interpret the skin sensitization potential of 5-chloro-2-methylisothiazol-3-one and 2-methylisothiazol-3-one. | 2005 Feb |
|
GSH depletion, protein S-glutathionylation and mitochondrial transmembrane potential hyperpolarization are early events in initiation of cell death induced by a mixture of isothiazolinones in HL60 cells. | 2006 Feb |
|
Airborne allergic contact dermatitis to methylchloroisothiazolinone/methylisothiazolinone in ironing water. | 2008 Mar |
|
Role of intracellular calcium and S-glutathionylation in cell death induced by a mixture of isothiazolinones in HL60 cells. | 2009 Mar |
|
Consumer exposure to biocides--identification of relevant sources and evaluation of possible health effects. | 2010 Feb 3 |
|
Prevalence and cause of methylisothiazolinone contact allergy. | 2010 Sep |
|
B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry. | 2012 Mar 25 |
|
Chemical allergens stimulate human epidermal keratinocytes to produce lymphangiogenic vascular endothelial growth factor. | 2015 Mar 1 |
Patents
Sample Use Guides
3 mcg of 5-chloro-2-methyl-4-isothiazolin-3-one (1.05% to 1.25% w/w) and 2-methyl-4-isothiazolin-3-one (0.25% to 0.40%w/w) in a 3:1 ratio per patch. Schedule patients to return approximately 48 hours after patch test application to have the panels removed.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6410231
Curator's Comment: Kathon is active at concentrations of 2.25–9 mg/mL active
ingredients against a wide range of bacteria and fungi.
https://www.google.ru/url?sa=t&rct=j&q=&esrc=s&source=web&cd=6&ved=0ahUKEwinisCBq8bPAhXI8ywKHWDrAJ8QFghGMAU&url=https%3A%2F%2Ffaculty.psau.edu.sa%2Ffiledownload%2Fdoc-7-pdf-61f3024ed641390e498517b310f7a378-original.pdf&usg=AFQjCNETPmioZMn6G6wNkDUJ6dSIgh59tA&sig2=uKNYTfPwwpRk83zu8Y96zA&bvm=bv.134495766,d.bGg
5-Chloro-2-methyl-4-isothiazolin-3-one inhibited growth in all test strains of Salmonella typhimurium without activation. A statistically significant increase in the number of revertants in strain TA100 was observed without activation at concentrations of 0.20, 0.25 and 0.30 ug/plate and in 2 of the 3 trials at 0.10 ug/plate.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:50:34 UTC 2023
by
admin
on
Fri Dec 15 15:50:34 UTC 2023
|
Record UNII |
DEL7T5QRPN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 704
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 999
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 569
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
||
|
EPA PESTICIDE CODE |
107103
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 675
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
||
|
NDF-RT |
N0000185508
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
||
|
CFR |
21 CFR 176.170
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
||
|
CFR |
21 CFR 175.320
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C011421
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | |||
|
SUB23424
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY | |||
|
DB14197
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY | |||
|
DEL7T5QRPN
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | |||
|
1367119
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | RxNorm | ||
|
N0000175629
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
m7433
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | |||
|
100000088728
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | |||
|
53621
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY | |||
|
33344
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | |||
|
METHYLCHLOROISOTHIAZOLINONE
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | |||
|
247-500-7
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY | |||
|
N0000171131
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
21 CFR 176.300
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY | |||
|
26172-55-4
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY | |||
|
N0000184306
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
8270
Created by
admin on Fri Dec 15 15:50:35 UTC 2023 , Edited by admin on Fri Dec 15 15:50:35 UTC 2023
|
PRIMARY | |||
|
DTXSID9034286
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY | |||
|
DEL7T5QRPN
Created by
admin on Fri Dec 15 15:50:34 UTC 2023 , Edited by admin on Fri Dec 15 15:50:34 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |